Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 317

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 317
---
ar and Omkar Halady. Our executive officers are not obligated to devote any specific number of hours to our matters but they intend to devote as much of their time as they deem necessary to Iris’s affairs until Iris has completed the Business Combination. The amount of time they will devote in any time period will vary based on the stage of the Business Combination process Iris is in. Iris does not intend to have any full time employees prior to the completion of the Business Combination. Directors and Executive Officers The below lists Iris’s officers and directors as of January 2, 2025. Concurrently with the consummation of the Business Combination, Iris’s officers and directors will resign from their respective positions at Iris and we expect that Mr. Chris Kim will be appointed as the President and Chief Executive Officer, Mr. Scott Dam, will be appointed as Chief Financial Officer, Mr. Byong C Yoo will be appointed Chief Science Officer, Mr. Sang-jin Daniel Lee will be appointed Head of Research and Development, and Mr. Beom K. Choi will be appointed as Chief Technology Officer.

| Name               | ​ | ​ | Age | ​ | ​ | Position                | ​ |
| Sumit Mehta        | ​ | ​ |  42 | ​ | ​ | Chief Executive Officer | ​ |
| Lisha Parmar       | ​ | ​ |  40 | ​ | ​ | Chief Financial Officer | ​ |
| Omkar Halady       | ​ | ​ |  40 | ​ | ​ | Vice President          | ​ |
| Rohit Nanani       | ​ | ​ |  50 | ​ | ​ | Director                | ​ |
| Richard Peretz     | ​ | ​ |  63 | ​ | ​ | Director                | ​ |
| Manish Shah        | ​ | ​ |  52 | ​ | ​ | Director                | ​ |
| Nicholas Fernandez | ​ | ​ |  41 | ​ | ​ | Director                | ​ |

Management Team Our management team is led by Sumit Mehta, our Chief Executive Officer, Lisha Parmar, our Chief Financial Officer, and Omkar Halady, our Vice President. Sumit Mehta is our Chief Executive Officer. Mr. Mehta was our Vice President from inception to May 2022. Mr. Mehta has been a managing director at Arrow Capital since 2019. He has over 15 years of experience across Corporate Finance, M&A and Private Equity, and a track record of identifying and executing successful